↓ Skip to main content

Dove Medical Press

Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile

Overview of attention for article published in Neuropsychiatric Disease and Treatment, July 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
25 Mendeley
Title
Clozapine Management in Schizophrenia Inpatients: A 5-Year Prospective Observational Study of Its Safety and Tolerability Profile
Published in
Neuropsychiatric Disease and Treatment, July 2021
DOI 10.2147/ndt.s312095
Pubmed ID
Authors

Renato de Filippis, Raffaele Gaetano, Georgios Schoretsanitis, Giuseppe Verde, Cesare Anthony Oliveti, John M Kane, Cristina Segura-Garcia, Pasquale De Fazio

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 16%
Student > Ph. D. Student 3 12%
Other 2 8%
Student > Postgraduate 2 8%
Student > Doctoral Student 1 4%
Other 1 4%
Unknown 12 48%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 16%
Medicine and Dentistry 4 16%
Nursing and Health Professions 1 4%
Arts and Humanities 1 4%
Unknown 15 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 July 2021.
All research outputs
#8,170,009
of 25,392,582 outputs
Outputs from Neuropsychiatric Disease and Treatment
#1,078
of 3,131 outputs
Outputs of similar age
#165,156
of 453,590 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#16
of 51 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 3,131 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,590 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.